Category:Ashling HOLLAND: Difference between revisions
Updating Category:Ashling_HOLLAND |
Updating Category:Ashling_HOLLAND |
||
| Line 2: | Line 2: | ||
=== Executive Summary === | === Executive Summary === | ||
Ashling HOLLAND is an inventor who has filed 1 patents. Their primary areas of innovation include | Ashling HOLLAND is an inventor who has filed 1 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (1 patents), Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations (1 patents), Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers (1 patents), and they have worked with companies such as PepGen Inc. (1 patents). Their most frequent collaborators include [[Category:Caroline GODFREY|Caroline GODFREY]] (1 collaborations), [[Category:Sonia BRACEGIRDLE|Sonia BRACEGIRDLE]] (1 collaborations), [[Category:Smita GUNNOO|Smita GUNNOO]] (1 collaborations). | ||
=== Patent Filing Activity === | === Patent Filing Activity === | ||
| Line 11: | Line 11: | ||
==== List of Technology Areas ==== | ==== List of Technology Areas ==== | ||
* [[:Category:CPC_C12N15/113|C12N15/113]] ( | * [[:Category:CPC_C12N15/113|C12N15/113]] (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents | ||
* [[:Category:CPC_A61K9/0019|A61K9/0019]] ( | * [[:Category:CPC_A61K9/0019|A61K9/0019]] (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents | ||
* [[:Category:CPC_A61K47/64|A61K47/64]] ( | * [[:Category:CPC_A61K47/64|A61K47/64]] (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents | ||
* [[:Category:CPC_A61P21/00|A61P21/00]] ( | * [[:Category:CPC_A61P21/00|A61P21/00]] (Drugs for disorders of the muscular or neuromuscular system): 1 patents | ||
* [[:Category:CPC_C07K7/08|C07K7/08]] ( | * [[:Category:CPC_C07K7/08|C07K7/08]] (PEPTIDES (peptides in foodstuffs): 1 patents | ||
* [[:Category:CPC_C12N2310/11|C12N2310/11]] ( | * [[:Category:CPC_C12N2310/11|C12N2310/11]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents | ||
* [[:Category:CPC_C12N2310/3233|C12N2310/3233]] ( | * [[:Category:CPC_C12N2310/3233|C12N2310/3233]] (modified ring structure): 1 patents | ||
=== Companies === | === Companies === | ||
Latest revision as of 06:39, 18 July 2024
Ashling HOLLAND
Executive Summary
Ashling HOLLAND is an inventor who has filed 1 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (1 patents), Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations (1 patents), Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers (1 patents), and they have worked with companies such as PepGen Inc. (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations), (1 collaborations).
Patent Filing Activity
File:Ashling HOLLAND Monthly Patent Applications.png
Technology Areas
File:Ashling HOLLAND Top Technology Areas.png
List of Technology Areas
- C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
- A61K9/0019 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
- A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents
- A61P21/00 (Drugs for disorders of the muscular or neuromuscular system): 1 patents
- C07K7/08 (PEPTIDES (peptides in foodstuffs): 1 patents
- C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
- C12N2310/3233 (modified ring structure): 1 patents
Companies
File:Ashling HOLLAND Top Companies.png
List of Companies
- PepGen Inc.: 1 patents
Collaborators
- Caroline GODFREY (1 collaborations)
- Sonia BRACEGIRDLE (1 collaborations)
- Smita GUNNOO (1 collaborations)
Subcategories
This category has the following 4 subcategories, out of 4 total.